Wojcik, Iwona
Schmidt, David E.
de Neef, Lisa A.
Rab, Minke A. E.
Meek, Bob
de Weerdt, Okke
Wuhrer, Manfred
van der Schoot, C. Ellen
Zwaginga, Jaap J.
de Haas, Masja
Falck, David
Vidarsson, Gestur
Funding for this research was provided by:
Horizon 2020 Framework Programme (Glycosylation Signatures for Precision Medicine project, GlySign, Grant No. 722095), Glycosylation Signatures for Precision Medicine project, GlySign, Grant No. 722095), Glycosylation Signatures for Precision Medicine project, GlySign, Grant No. 722095), Glycosylation Signatures for Precision Medicine project, GlySign, Grant No. 722095))
Landsteiner Foundation for Blood Transfusion Research (Grant No. 1546, Grant No. 1546, Grant No. 1546, Grant No. 1546)
Studienstiftung des Deutschen Volkes (Scholarship)
Article History
Received: 16 September 2021
Accepted: 23 November 2021
First Online: 15 December 2021
Competing interests
: I.W. is employed by Genos Ltd. No potential conflict of interest was reported by the remaining authors.